Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

NKTRNKTR
5 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in Nektar Therapeutics

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 278,977 shares of NKTR (Nektar Therapeutics), worth $19.5M as of 2026-Q2. The position was increased (+12.0% shares). NKTR represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$19.5M

Current Shares

278,977

Total Value Change

+$13.7M

Total Shares Change

+57,086

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
278,977
+12.0%
$19.5M0.0%$69.81
32
2026-Q1
Decreased
249,090
-35.0%
$17.9M0.0%$68.11
0
2025-Q4
Decreased
383,310
-58.6%
$16.2M0.0%$41.90
0
2025-Q3
Increased
924,896
+316.8%
$52.6M0.0%$58.92
47
2025-Q2
New
221,891
-
$5.7M0.0%$25.76
37

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used